Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With Cystinosis
NCT01744782
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Cystinosis
Interventions
DRUG:
RP103
Sponsor
Amgen